Figure 3

SP-ELISA to detect in patient sera anti-Adalimumab antibodies using: (A) peptide HC3 and (B) peptide LC3. Selected patients were Adalimumab treated JIA (n = 29) and non-treated JIA (n = 8). Conservative cut-off values were set by receiver-operator curve analysis (Fig. 1).